ESC 365 - PCSK9 inhibitors: ready to embrace? Conclusion.

ESC Premium Access

PCSK9 inhibitors: ready to embrace? Conclusion.

Session: PCSK9 inhibitors: ready to embrace?

Topic: Drug therapy

Speaker: Professor H. Drexel (Feldkirch, AT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)

17 presentations

4 followers

4 more presentations in this session

PCSK9 inhibitors: ready to embrace? - Positioning of the topic

Speaker: Professor M. Sabatine (Boston, US)

PCSK9 inhibitors are ready for daily life clincial use - PRO

Speaker: Professor E. Navarese (Sassari, IT)

PCSK9 inhibitors are ready for daily life clincial use - CON

Speaker: Professor T. Pedersen (Oslo, NO)

PCSK9 inhibitors are ready for daily life clincial use -Discussion PRO/CONTRA.

Access the full session

PCSK9 inhibitors: ready to embrace?

Speakers: Professor H. Drexel, Professor M. Sabatine, Professor E. Navarese, Professor T. Pedersen

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources